Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE…
The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity…
Eterna reports the development of an mRNA-engineered iPSC line developed using UltraSlice™ to express a B2M-HLA-E fusion transgene in lieu…
WARMINSTER, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive…
Findings From These Studies Could Save Thousands of Lives Through Better Understanding the Mechanistic Basis of Chronic Wound InfectionORLANDO, FL…
Canadians in over 150 communities coast-to-coast will walk as one the weekend of May 25th in support of those living…
LONDON, May 03, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access…
Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and integrated health systemsMUMBAI, India &…
ANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE…
Industry-Leading Clinical NGS Test Provider MicroGenDX Has Created a New Patient-Focused Website to Improve Access and Discovery of Its D2C…